{{Rsnum
|rsid=10782529
|Chromosome=1
|position=84802560
|Orientation=plus
|GMAF=0.348
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 11.5 | 41.6 | 46.9
| HCB | 10.9 | 42.3 | 46.7
| JPT | 11.5 | 52.2 | 36.3
| YRI | 5.4 | 33.3 | 61.2
| ASW | 3.5 | 33.3 | 63.2
| CHB | 10.9 | 42.3 | 46.7
| CHD | 11.0 | 43.1 | 45.9
| GIH | 9.9 | 37.6 | 52.5
| LWK | 6.4 | 39.1 | 54.5
| MEX | 6.9 | 65.5 | 27.6
| MKK | 12.8 | 48.7 | 38.5
| TSI | 10.8 | 46.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23118302
  |Trait=Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
  |Title=Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
  |RiskAllele=C
  |Pval=4E-6
  |OR=1.70
  |ORtxt=[1.11-2.29] percent increase
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}